Pangea Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PANGEA
PANGEA has seven approved drugs.
Drugs and US Patents for Pangea
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pangea | CELECOXIB | celecoxib | CAPSULE;ORAL | 212925-002 | Dec 9, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Pangea | OXAPROZIN | oxaprozin | TABLET;ORAL | 075845-001 | Jan 31, 2001 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pangea | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 088149-001 | Apr 28, 1983 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Pangea | ETODOLAC | etodolac | TABLET;ORAL | 074903-002 | Apr 19, 1999 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pangea | ETODOLAC | etodolac | TABLET;ORAL | 074903-001 | Apr 11, 1997 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Pangea
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pangea | PRIMSOL | trimethoprim hydrochloride | SOLUTION;ORAL | 074973-001 | Jan 24, 2000 | 5,763,449 | ⤷ Start Trial |
| Pangea | PRIMSOL | trimethoprim hydrochloride | SOLUTION;ORAL | 074973-001 | Jan 24, 2000 | 5,962,461 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

